TY - JOUR AU - Angus, D. C. AU - van der Poll, T. PY - 2013 DA - 2013// TI - Severe sepsis and septic shock JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMra1208623 DO - 10.1056/NEJMra1208623 ID - Angus2013 ER - TY - JOUR AU - Brun-Buisson, C. AU - Doyon, F. AU - Carlet, J. AU - Dellamonica, P. AU - Gouin, F. AU - Lepoutre, A. AU - Mercier, J. C. AU - Offenstadt, G. AU - Regnier, B. PY - 1995 DA - 1995// TI - Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units JO - JAMA VL - 274 UR - https://doi.org/10.1001/jama.1995.03530120060042 DO - 10.1001/jama.1995.03530120060042 ID - Brun-Buisson1995 ER - TY - JOUR AU - Schoenberg, M. H. AU - Weiss, M. AU - Radermacher, P. PY - 1998 DA - 1998// TI - Outcome of patients with sepsis and septic shock after ICU treatment JO - Langenbecks Arch Surg VL - 383 UR - https://doi.org/10.1007/s004230050090 DO - 10.1007/s004230050090 ID - Schoenberg1998 ER - TY - JOUR AU - Martin, G. S. AU - Mannino, D. M. AU - Eaton, S. AU - Moss, M. PY - 2003 DA - 2003// TI - The epidemiology of sepsis in the United States from 1979 through 2000 JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022139 DO - 10.1056/NEJMoa022139 ID - Martin2003 ER - TY - JOUR AU - Fortenberry, J. D. AU - Paden, M. L. PY - 2006 DA - 2006// TI - Extracorporeal therapies in the treatment of sepsis: experience and promise JO - Semin Pediatr Infect Dis VL - 17 UR - https://doi.org/10.1053/j.spid.2006.04.005 DO - 10.1053/j.spid.2006.04.005 ID - Fortenberry2006 ER - TY - JOUR AU - Szczepiorkowski, Z. M. AU - Winters, J. L. AU - Bandarenko, N. AU - Kim, H. C. AU - Linenberger, M. L. AU - Marques, M. B. AU - Sarode, R. AU - Schwartz, J. AU - Weinstein, R. AU - Shaz, B. H. PY - 2010 DA - 2010// TI - Apheresis Applications Committee of the American Society for A: Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis JO - J Clin Apher VL - 25 UR - https://doi.org/10.1002/jca.20240 DO - 10.1002/jca.20240 ID - Szczepiorkowski2010 ER - TY - JOUR AU - Stegmayr, B. PY - 2008 DA - 2008// TI - Apheresis in patients with severe sepsis and multi organ dysfunction syndrome JO - Transfus Apher Sci VL - 38 UR - https://doi.org/10.1016/j.transci.2008.03.009 DO - 10.1016/j.transci.2008.03.009 ID - Stegmayr2008 ER - TY - JOUR AU - Vain, N. E. AU - Mazlumian, J. R. AU - Swarner, O. W. AU - Cha, C. C. PY - 1980 DA - 1980// TI - Role of exchange transfusion in the treatment of severe septicemia JO - Pediatrics VL - 66 ID - Vain1980 ER - TY - JOUR AU - Bjorvatn, B. AU - Bjertnaes, L. AU - Fadnes, H. O. AU - Flaegstad, T. AU - Gutteberg, T. J. AU - Kristiansen, B. E. AU - Pape, J. AU - Rekvig, O. P. AU - Osterud, B. AU - Aanderud, L. PY - 1984 DA - 1984// TI - Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange JO - Br Med J VL - 288 UR - https://doi.org/10.1136/bmj.288.6415.439 DO - 10.1136/bmj.288.6415.439 ID - Bjorvatn1984 ER - TY - JOUR AU - Brandtzaeg, P. AU - Sirnes, K. AU - Folsland, B. PY - 1985 DA - 1985// TI - Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients JO - Scand J Clin Lab Invest VL - 45 ID - Brandtzaeg1985 ER - TY - JOUR AU - Drapkin, M. S. AU - Wisch, J. S. AU - Gelfand, J. A. AU - Cannon, J. G. AU - Dinarello, C. A. PY - 1989 DA - 1989// TI - Plasmapheresis for fulminant meningococcemia JO - Pediatr Infect Dis J VL - 8 UR - https://doi.org/10.1097/00006454-198906000-00015 DO - 10.1097/00006454-198906000-00015 ID - Drapkin1989 ER - TY - JOUR AU - Scharfman, W. B. AU - Tillotson, J. R. AU - Taft, E. G. AU - Wright, E. PY - 1979 DA - 1979// TI - Plasmapheresis for meningococcemia with disseminated intravascular coagulation JO - N Engl J Med VL - 300 ID - Scharfman1979 ER - TY - JOUR AU - Schmidt, J. AU - Mann, S. AU - Mohr, V. D. AU - Lampert, R. AU - Firla, U. AU - Zirngibl, H. PY - 2000 DA - 2000// TI - Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis JO - Intensive Care Med VL - 26 UR - https://doi.org/10.1007/s001340051200 DO - 10.1007/s001340051200 ID - Schmidt2000 ER - TY - JOUR AU - Van Deuren, M. AU - Santman, F. W. AU - Van Dalen, R. AU - Sauerwein, R. W. AU - Span, L. F. R. AU - Van der Meer, J. W. M. PY - 1992 DA - 1992// TI - Plasma and whole blood exchange in meningococcal sepsis JO - Clin Infect Dis VL - 15 UR - https://doi.org/10.1093/clind/15.3.424 DO - 10.1093/clind/15.3.424 ID - Van Deuren1992 ER - TY - JOUR AU - Gardlund, B. AU - Sjolin, J. AU - Nilsson, A. AU - Roll, M. AU - Wickerts, C. J. AU - Wikstrom, B. AU - Wretlind, B. PY - 1993 DA - 1993// TI - Plasmapheresis in the treatment of primary septic shock in humans JO - Scand J Infect Dis VL - 25 UR - https://doi.org/10.3109/00365549309008575 DO - 10.3109/00365549309008575 ID - Gardlund1993 ER - TY - JOUR AU - Stegmayr, B. G. PY - 1996 DA - 1996// TI - Plasma exchange in patients with septic shock including acute renal failure JO - Blood Purif VL - 14 UR - https://doi.org/10.1159/000170251 DO - 10.1159/000170251 ID - Stegmayr1996 ER - TY - STD TI - Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D: Methodological Expectations of Cochrane Intervention Reviews (MECIR) methodological standards for the conduct of new Cochrane Intervention Reviews, Version 2.1. The Cochrane Collaboration; 2011. [www.editorial-unit.cochrane.org/mecir] UR - http://www.editorial-unit.cochrane.org/mecir ID - ref17 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2535 DO - 10.1136/bmj.b2535 ID - Moher2009 ER - TY - STD TI - Higgins JP, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 edition. The Cochrance Collaboration; 2011. [www.cochrane-handbook.org] UR - http://www.cochrane-handbook.org ID - ref19 ER - TY - STD TI - Higgins JPT, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration; 2008. [www.cochrane-handbook.org] UR - http://www.cochrane-handbook.org ID - ref20 ER - TY - JOUR AU - Julian, P. T. H. AU - Douglas, G. A. AU - Peter, C. G. AU - Peter, J. Ã. AU - David, M. AU - Andrew, D. O. AU - Jelena, S. AU - Kenneth, F. S. AU - Laura, W. AU - Jonathan, A. C. S. PY - 2011 DA - 2011// TI - The Cochrane Collaboration™ tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Julian2011 ER - TY - JOUR AU - Knaus, W. A. AU - Draper, E. A. PY - 1985 DA - 1985// TI - APACHE II: A severity of disease classification system JO - Crit Care Med VL - 13 UR - https://doi.org/10.1097/00003246-198510000-00009 DO - 10.1097/00003246-198510000-00009 ID - Knaus1985 ER - TY - JOUR AU - Reeves, J. H. AU - Butt, W. W. AU - Shann, F. AU - Layton, J. E. AU - Stewart, A. AU - Waring, P. M. AU - Presneill, J. J. PY - 1999 DA - 1999// TI - Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group JO - Crit Care Med VL - 27 UR - https://doi.org/10.1097/00003246-199910000-00003 DO - 10.1097/00003246-199910000-00003 ID - Reeves1999 ER - TY - JOUR AU - Busund, R. AU - Koukline, V. AU - Utrobin, U. AU - Nedashkovsky, E. PY - 2002 DA - 2002// TI - Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial JO - Intensive Care Med VL - 28 UR - https://doi.org/10.1007/s00134-002-1410-7 DO - 10.1007/s00134-002-1410-7 ID - Busund2002 ER - TY - JOUR AU - Nguyen, T. C. AU - Han, Y. Y. AU - Kiss, J. E. AU - Hall, M. W. AU - Hassett, A. C. AU - Jaffe, R. AU - Orr, R. A. AU - Janosky, J. AU - Carcillo, J. A. PY - 2008 DA - 2008// TI - Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure JO - Crit Care Med VL - 36 UR - https://doi.org/10.1097/CCM.0b013e318186aa49 DO - 10.1097/CCM.0b013e318186aa49 ID - Nguyen2008 ER - TY - JOUR AU - Long, E. J. AU - Shann, F. AU - Pearson, G. AU - Buckley, D. AU - Butt, W. PY - 2013 DA - 2013// TI - A randomised controlled trial of plasma filtration in severe paediatric sepsis JO - Crit Care Resusc VL - 15 ID - Long2013 ER - TY - JOUR AU - Aird, W. C. PY - 2003 DA - 2003// TI - The hematologic system as a marker of organ dysfunction in sepsis JO - Mayo Clin Proc VL - 78 UR - https://doi.org/10.4065/78.7.869 DO - 10.4065/78.7.869 ID - Aird2003 ER - TY - JOUR AU - Levy, M. M. AU - Fink, M. P. AU - Marshall, J. C. AU - Abraham, E. AU - Angus, D. AU - Cook, D. AU - Cohen, J. AU - Opal, S. M. AU - Vincent, J. -. L. AU - Ramsay, G. PY - 2003 DA - 2003// TI - SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/01.CCM.0000050454.01978.3B DO - 10.1097/01.CCM.0000050454.01978.3B ID - Levy2003 ER - TY - JOUR AU - Matthay, M. A. PY - 2001 DA - 2001// TI - Severe sepsis – a new treatment with both anticoagulant and antiinflammatory properties JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103083441009 DO - 10.1056/NEJM200103083441009 ID - Matthay2001 ER - TY - JOUR AU - Levi, M. AU - Schultz, M. AU - van der Poll, T. PY - 2011 DA - 2011// TI - Coagulation biomarkers in critically ill patients JO - Crit Care Clin VL - 27 UR - https://doi.org/10.1016/j.ccc.2010.12.009 DO - 10.1016/j.ccc.2010.12.009 ID - Levi2011 ER - TY - JOUR AU - Toltl, L. J. AU - Swystun, L. L. AU - Pepler, L. AU - Liaw, P. C. PY - 2008 DA - 2008// TI - Protective effects of activated protein C in sepsis JO - Thromb Haemost VL - 100 ID - Toltl2008 ER - TY - JOUR AU - Afshari, A. AU - Wetterslev, J. AU - Brok, J. AU - Moller, A. PY - 2007 DA - 2007// TI - Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis JO - BMJ VL - 335 UR - https://doi.org/10.1136/bmj.39398.682500.25 DO - 10.1136/bmj.39398.682500.25 ID - Afshari2007 ER - TY - JOUR AU - Bernard, G. R. AU - Vincent, J. L. AU - Laterre, P. F. AU - LaRosa, S. P. AU - Dhainaut, J. F. AU - Lopez-Rodriguez, A. AU - Steingrub, J. S. AU - Garber, G. E. AU - Helterbrand, J. D. AU - Ely, E. W. AU - Fisher, C. J. PY - 2001 DA - 2001// TI - Efficacy and safety of recombinant human activated protein C for severe sepsis JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103083441001 DO - 10.1056/NEJM200103083441001 ID - Bernard2001 ER - TY - JOUR AU - Esmon, C. T. PY - 2000 DA - 2000// TI - Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? JO - Blood VL - 95 ID - Esmon2000 ER - TY - JOUR AU - Abraham, E. AU - Reinhart, K. AU - Opal, S. AU - Demeyer, I. AU - Doig, C. AU - Rodriguez, A. L. AU - Beale, R. AU - Svoboda, P. AU - Laterre, P. F. AU - Simon, S. AU - Light, B. AU - Spapen, H. AU - Stone, J. AU - Seibert, A. AU - Peckelsen, C. AU - De Deyne, C. AU - Postier, R. AU - Pettila, V. AU - Artigas, A. AU - Percell, S. R. AU - Shu, V. AU - Zwingelstein, C. AU - Tobias, J. AU - Poole, L. AU - Stolzenbach, J. C. AU - Creasey, A. A. PY - 2003 DA - 2003// TI - Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.2.238 DO - 10.1001/jama.290.2.238 ID - Abraham2003 ER - TY - JOUR AU - Fisher, C. J. AU - Dhainaut, J. F. AU - Opal, S. M. AU - Pribble, J. P. AU - Balk, R. A. AU - Slotman, G. J. AU - Iberti, T. J. AU - Rackow, E. C. AU - Shapiro, M. J. AU - Greenman, R. L. AU - Reines, H. D. AU - Shelly, M. P. AU - Thompson, B. W. AU - LaBrecque, J. F. AU - Catalano, M. A. AU - Knaus, W. A. AU - Sadoff, J. C. AU - Phase, I. I. I. PY - 1994 DA - 1994// TI - Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group JO - JAMA VL - 271 UR - https://doi.org/10.1001/jama.1994.03510470040032 DO - 10.1001/jama.1994.03510470040032 ID - Fisher1994 ER - TY - JOUR AU - Bone, R. C. AU - Balk, R. A. AU - Fein, A. M. AU - Perl, T. M. AU - Wenzel, R. P. AU - Reines, H. D. AU - Quenzer, R. W. AU - Iberti, T. J. AU - Macintyre, N. AU - Schein, R. M. PY - 1995 DA - 1995// TI - A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group JO - Crit Care Med VL - 23 UR - https://doi.org/10.1097/00003246-199506000-00003 DO - 10.1097/00003246-199506000-00003 ID - Bone1995 ER - TY - JOUR AU - Cohen, J. AU - Carlet, J. PY - 1996 DA - 1996// TI - INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group JO - Crit Care Med VL - 24 UR - https://doi.org/10.1097/00003246-199609000-00002 DO - 10.1097/00003246-199609000-00002 ID - Cohen1996 ER - TY - JOUR AU - Abraham, E. AU - Wunderink, R. AU - Silverman, H. AU - Perl, T. M. AU - Nasraway, S. AU - Levy, H. AU - Bone, R. AU - Wenzel, R. P. AU - Balk, R. AU - Allred, R. AU - Pennington, J. E. AU - Wherry, J. C. PY - 1995 DA - 1995// TI - Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group JO - JAMA VL - 273 UR - https://doi.org/10.1001/jama.1995.03520360048038 DO - 10.1001/jama.1995.03520360048038 ID - Abraham1995 ER - TY - JOUR AU - Ronco, C. AU - Tetta, C. AU - Mariano, F. AU - Wratten, M. L. AU - Bonello, M. AU - Bordoni, V. AU - Cardona, X. AU - Inguaggiato, P. AU - Pilotto, L. AU - D’Intini, V. AU - Bellomo, R. PY - 2003 DA - 2003// TI - Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis JO - Artif Organs VL - 27 UR - https://doi.org/10.1046/j.1525-1594.2003.07289.x DO - 10.1046/j.1525-1594.2003.07289.x ID - Ronco2003 ER - TY - JOUR AU - Rock, G. A. AU - Shumak, K. H. AU - Buskard, N. A. AU - Blanchette, V. S. AU - Kelton, J. G. AU - Nair, R. C. AU - Spasoff, R. A. PY - 1991 DA - 1991// TI - Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group JO - N Engl J Med VL - 325 UR - https://doi.org/10.1056/NEJM199108083250604 DO - 10.1056/NEJM199108083250604 ID - Rock1991 ER - TY - JOUR AU - Cinel, I. AU - Opal, S. M. PY - 2009 DA - 2009// TI - Molecular biology of inflammation and sepsis: a primer JO - Crit Care Med VL - 37 UR - https://doi.org/10.1097/CCM.0b013e31819267fb DO - 10.1097/CCM.0b013e31819267fb ID - Cinel2009 ER - TY - JOUR AU - Zhou, F. AU - Peng, Z. AU - Murugan, R. AU - Kellum, J. A. PY - 2013 DA - 2013// TI - Blood purification and mortality in sepsis: a meta-analysis of randomized trials JO - Crit Care Med VL - 41 UR - https://doi.org/10.1097/CCM.0b013e31828cf412 DO - 10.1097/CCM.0b013e31828cf412 ID - Zhou2013 ER - TY - JOUR AU - Livigni, S. AU - Bertolini, G. AU - Rossi, C. AU - Ferrari, F. AU - Giardino, M. AU - Pozzato, M. AU - Remuzzi, G. PY - 2014 DA - 2014// TI - Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-003536 DO - 10.1136/bmjopen-2013-003536 ID - Livigni2014 ER - TY - JOUR AU - Taori, G. AU - Ho, K. M. AU - George, C. AU - Bellomo, R. AU - Webb, S. A. AU - Hart, G. K. AU - Bailey, M. J. PY - 2009 DA - 2009// TI - Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis JO - Crit Care VL - 13 UR - https://doi.org/10.1186/cc7988 DO - 10.1186/cc7988 ID - Taori2009 ER - TY - JOUR AU - McGee, D. C. AU - Gould, M. K. PY - 2003 DA - 2003// TI - Preventing complications of central venous catheterization JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMra011883 DO - 10.1056/NEJMra011883 ID - McGee2003 ER - TY - JOUR AU - Basic-Jukic, N. AU - Kes, P. AU - Glavas-Boras, S. AU - Brunetta, B. AU - Bubic-Filipi, L. AU - Puretic, Z. PY - 2005 DA - 2005// TI - Complications of therapeutic plasma exchange: experience with 4857 treatments JO - Ther Apher Dial VL - 9 UR - https://doi.org/10.1111/j.1744-9987.2005.00319.x DO - 10.1111/j.1744-9987.2005.00319.x ID - Basic-Jukic2005 ER -